DiBenedetti D, Sollano JA, Kolotkin RL. The impact of being overweight on health-related quality of life in type 2 diabetic patients: patient interviews. Poster presented at the Obesity Society’s 2008 Annual Scientific Meeting; October 2008.
Donatti C, Wild D, Horblyuk R, Beusterien KM, Anderson R, Arondekar B, DiBenedetti DB. Psychometric evaluation of the satisfaction with Oral Anti-Diabetic Agent Scale. Diabetes Res Clin Pract. 2008 Apr;80(1):108-13.
Deal L, DiBenedetti DB, Fehnel SE, Williams VS. Development and psychometric validation of the endometriosis treatment satisfaction questionnaire (ETSQ). Presented at the 10th World Congress on Endometriosis; March 1, 2008.
Deal L, DiBenedetti DB, Fehnel SE, Williams VS. Development and preliminary validation of the daily endometriosis pain and bleeding diary. Poster presented at the 10th World Congress on Endometriosis; March 1, 2008.
Edin HM, DiBenedetti D, Hill CD. Adherence among patients with Parkinson's Disease taking ropinirole immediate release at least three times daily. Poster presented at the Movement Disorders Society; June 13, 2008. [abstract] Mov Disord. 2008; 23:S344-5.
Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, Levine KB, Jordan J, Clark RV. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008 Jan 1;11(1):32-43.
David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec 1;5(6):935-42.
Kubin M, Britt D, Trudeau E, Fugl-Meyer A, Gondek K. Patient and partner treatment satisfaction scale (TSS) in erectile dysfunction. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain.
Britt D, Kubin M, Keininger D, Trudeau E, Sagnier P, Beneke M. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. J Sex Med. 2003 Oct;25(Suppl 5):S180.
Britt DM, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Poster presented at the 2nd International Consultation on Erectile and Sexual Dysfunctions; June 2003.
Britt D, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Pharmacotherapy. 2003 Jun;23(10):132.
Baldus T, Nehra A, Brock G, Britt DM. Influence of vardenafil, a potent, highly selective phosphodiesterase-5 inhibitor on improving erectile function and depressive symptomatology in patients with erectile dysfunction secondary to radical nerve-sparing prostatectomy. Poster presented at the 31st Annual Meeting of the American Academy of Physician Assistants; May 2003.